Cập nhật tin tức quốc tế

Tin tức Y tế

Cập nhật tin tức quốc tế

137 Tin tức Y tế
Cập nhật tin tức quốc tế Oral GLP-1 Receptor Agonist Reduces CV Risk
Oral GLP-1 Receptor Agonist Reduces CV Risk

T2D who have cardiovascular disease, CKD, or both, the oral formulation of semaglutide GLP-1 recept...

Cập nhật tin tức quốc tế Two Key Recommendations for Outpatient Treatment of Acute Migraine in New ACP Guidelines
Two Key Recommendations for Outpatient Treatment of Acute Migraine in New ACP Guidelines

The ACP developed this guideline based on the best available evidence on the benefits, harms, patien...

Cập nhật tin tức quốc tế Major Changes Highlighted in New CKD Management Guidelines
Major Changes Highlighted in New CKD Management Guidelines

Updates on chronic kidney disease (CKD) diagnosis, use of sodium–glucose cotransporter-2 (SGLT-2) in...

Cập nhật tin tức quốc tế Junk Food Binge May Alter Brain Insulin Response
Junk Food Binge May Alter Brain Insulin Response

Researchers postulated that brain insulin responsiveness may adapt to dietary changes before weight...

Cập nhật tin tức quốc tế Subcutaneous Guselkumab Proves Efficacious for IBD in Two Studies: ASTRO and GRAVITI
Subcutaneous Guselkumab Proves Efficacious for IBD in Two Studies: ASTRO and GRAVITI

Induction therapy with subcutaneous guselkumab demonstrated significant efficacy in patients with mo...

Cập nhật tin tức quốc tế Is This the Tipping Point to Slash Salt in Our Diet
Is This the Tipping Point to Slash Salt in Our Diet

For adults, WHO recommends less than 2000 mg/day of sodium (equivalent to less than 5 g/day salt), o...

Cập nhật tin tức quốc tế 2025 AACE Publishes Guideline on Drug Management of Dyslipidemia
2025 AACE Publishes Guideline on Drug Management of Dyslipidemia

A new dyslipidemia guideline from the American Association of Clinical Endocrinology (AACE)

Cập nhật tin tức quốc tế Romosozumab Improves Bone Strength in Women With T2D
Romosozumab Improves Bone Strength in Women With T2D

Romosozumab for 12 months followed by alendronate for 24 months leads to greater improvements in lum...

Cập nhật tin tức quốc tế FDA OKs First-In-Class Nonopioid Pain Med Suzetrigine
FDA OKs First-In-Class Nonopioid Pain Med Suzetrigine

The US Food and Drug Administration (FDA) has approved suzetrigine 50 mg tablets, a first-in-class n...